About TORL Biotherapeutics
TORL Biotherapeutics is a private company based in Culver City, California. It has reported $158,300,000 raised in one offering on Form D since April 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 2024 | Apr 17, 2024 | $158,300,000fully sold | 52 | $3.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on TORL Biotherapeutics's Form D filed Apr 17, 2024.
MA
Mark Alles
Executive officer and director
MA
Mark Attanasio
Director
DL
David Licata
President and director
NB
Neil O'Brien
Director
AS
Amit Sinha
Director
LS
Lynn Seely
Director
DS
Dennis Slamon
Director